巴西关于结直肠癌肝转移多模式治疗的首个共识。模块1：预处理评估。
FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.
作者信息
Coimbra Felipe José Fernandez, Ribeiro Heber Salvador de Castro, Marques Márcio Carmona, Herman Paulo, Chojniak Rubens, Kalil Antonio Nocchi, Wiermann Evanius Garcia, Cavallero Sandro Roberto de Araújo, Coelho Fabricio Ferreira, Fernandes Paulo Henrique de Souza, Silvestrini Anderson Arantes, Almeida Maria Fernanda Arruda, de Araújo Antônio Luis Eiras, Pitombo Marcos, Teixeira Heberton Medeiros, Waechter Fábio Luiz, Ferreira Fábio Gonçalves, Diniz Alessandro Landskron, D'Ippolito Giuseppe, D'Ippolito Giuseppe, Begnami Maria Dirlei F de Sousa, Prolla Gabriel, Balzan Silvio Márcio Pegoraro, de Oliveira Thiago Bueno, Szultan Luís Arnaldo, Lendoire Javier, Torres Orlando Jorge Martins
机构信息
American Hepato-Pancreato-Biliary Association, São Paulo, Brazil.
出版信息
Arq Bras Cir Dig. 2015 Nov-Dec;28(4):222-30. doi: 10.1590/S0102-6720201500040002.
BACKGROUND
Liver metastases of colorectal cancer are frequent and potentially fatal event in the evolution of patients with these tumors.
AIM
In this module, was contextualized the clinical situations and parameterized epidemiological data and results of the various treatment modalities established.
METHOD
Was realized deep discussion on detecting and staging metastatic colorectal cancer, as well as employment of imaging methods in the evaluation of response to instituted systemic therapy.
RESULTS
The next step was based on the definition of which patients would have their metastases considered resectable and how to expand the amount of patients elegible for modalities with curative intent.
CONCLUSION
Were presented clinical, pathological and molecular prognostic factors, validated to be taken into account in clinical practice.
背景
在患有这些肿瘤的患者病程中，结直肠癌肝转移是常见且可能致命的事件。
目的
在本模块中，对临床情况进行了背景分析，对各种既定治疗方式的流行病学数据和结果进行了参数化处理。
方法
对转移性结直肠癌的检测和分期以及在评估对既定全身治疗的反应中使用成像方法进行了深入讨论。
结果
下一步基于确定哪些患者的转移灶被认为可切除，以及如何增加适合根治性治疗方式的患者数量。
结论
介绍了经临床验证可在临床实践中考虑的临床、病理和分子预后因素。
Zotero 插件